Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

New acne treatments show promise as alternatives to traditional therapies.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Secukinumab effectively treated a difficult case of folliculitis decalvans.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Researchers found a gene in hamsters that responds to male hormones and may be indirectly controlled by them.

Finasteride may help treat autism by reducing inflammation and oxidative stress.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Minoxidil helps hair regrowth and has anti-aging effects on hair follicles.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

The document concludes that a new method has been developed to test anti-aging substances on human skin, showing that these substances can reduce skin aging signs.

Cholecystokinin may help reduce skin inflammation in psoriasis.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Skin bacteria, specifically Staphylococcus aureus, help in wound healing and hair growth by using IL-1β signaling. Using antibiotics on skin wounds can slow down this natural healing process.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Finasteride causes temporary cell death in BPH tissues.

The expected density of a hair transplant depends on the number of hair follicles transplanted and the thickness of the hair.